Concentrix Corporation Common Stock (CNXC)

FairStock Score: 46/100 — MIXED

Key Financials

Strengths

• Generates $517 million in annual free cash flow (32.3% yield on market cap)
• Attractive 6.2% dividend yield providing steady income returns
• Established organization with 4,55,000 employees providing operational scale

Concerns

• High leverage at 2.04x debt-to-equity increases financial risk and interest expense burden
• Weak Piotroski F-Score of 3/9 suggests deteriorating financial quality across multiple dimensions
• Altman Z-Score of 0.4 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Concentrix Corporation Common Stock is a micro-cap technology company valued at $1.6 billion. The business generates $10.0 billion in annual revenue with a 0.2% net margin and $517 million in free cash flow. From a quality standpoint, Concentrix shows weak Piotroski F-Score of 3/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 0.4 warrants caution. Growth dynamics show revenue growing at 5.4% and profit growth of -69.3%. The 6.2% dividend yield adds an income component for patient holders. Our composite FairStock Score of 46/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $517 million in annual free cash flow (32.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Elevated leverage at 2.0x D/E means rising interest rates or revenue weakness could strain debt covenants and force asset sales at distressed prices. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer